Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Humacyte, Inc.HUMA · Entity 6478 | Director | October 06, 2026 | October 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Humacyte, Inc.
Report date October 06, 2026 · Filed October 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.48 · Expires 2036-10-06 | Direct | 125,000 |
Reported balance
After 2026-10-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-10-06 · Grant · Acquired 125,000 · Balance 125,000 F1: The first 25% of the option becomes exercisable on October 6, 2027, after which 1/48 of the option becomes exercisable on the 6th day of each month thereafter, with the option becoming fully vested on October 6, 2030. |
Filing footnotes · ownership attribution and instrument terms
F1: The first 25% of the option becomes exercisable on October 6, 2027, after which 1/48 of the option becomes exercisable on the 6th day of each month thereafter, with the option becoming fully vested on October 6, 2030.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
EXACT SCIENCES CORP
Report date March 23, 2026 · Filed March 23, 2026
Section 16 reporting ended · disclosed 2026-03-23. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2026-03-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-23 · Disposition to issuer · Disposed 52,164 · Balance 5,398 F1: On March 23, 2026, pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of November 19, 2025, by and among Exact Sciences Corporation, a Delaware corporation (the "Issuer"), Abbott Laboratories, an Illinois corporation ("Parent"), and Badger Merger Sub I, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a direct, wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), on the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), issued and outstanding immediately prior to the Effective Time, with certain exceptions, was converted into the right to receive $105.00 in cash, without interest (the "Merger Consideration"). Row 2 · 2026-03-23 · Disposition to issuer · Disposed 5,398 · Balance 0 F2: At the Effective Time, each share of Common Stock subject to vesting, repurchase or other lapse restriction and that was granted under an Issuer stock plan and outstanding as of immediately prior to the Effective Time was deemed to be fully vested and cancelled and converted into the right to receive the Merger Consideration, less any applicable tax withholding. |
| Common StockSEC Table I · non-derivative | IndirectHeld in 401(k) Plan | 0 |
Reported balance
After 2026-03-23 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2026-03-23 · Disposition to issuer · Disposed 4,694 · Balance 0 F1: On March 23, 2026, pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of November 19, 2025, by and among Exact Sciences Corporation, a Delaware corporation (the "Issuer"), Abbott Laboratories, an Illinois corporation ("Parent"), and Badger Merger Sub I, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a direct, wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), on the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), issued and outstanding immediately prior to the Effective Time, with certain exceptions, was converted into the right to receive $105.00 in cash, without interest (the "Merger Consideration"). |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $44.37 | Direct | 0 |
Reported balance
After 2026-03-23 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-03-23 · Disposition to issuer · Disposed 4,175 · Balance 0 F4: At the Effective Time, each option to purchase shares of Common Stock granted under an Issuer stock plan and outstanding and unexercised as of immediately prior to the Effective Time was cancelled and, in the case of any such option the per-share exercise price of which was less than the Merger Consideration, converted into the right to receive a cash payment equal to the number of shares of Common Stock for which such option was exercisable multiplied by the excess of the Merger Consideration over the per-share exercise price of such option, less any applicable tax withholding F3: These options became exercisable on February 27, 2022. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $92.62 | Direct | 0 |
Reported balance
After 2026-03-23 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-03-23 · Disposition to issuer · Disposed 10,786 · Balance 0 F4: At the Effective Time, each option to purchase shares of Common Stock granted under an Issuer stock plan and outstanding and unexercised as of immediately prior to the Effective Time was cancelled and, in the case of any such option the per-share exercise price of which was less than the Merger Consideration, converted into the right to receive a cash payment equal to the number of shares of Common Stock for which such option was exercisable multiplied by the excess of the Merger Consideration over the per-share exercise price of such option, less any applicable tax withholding F5: These options became exercisable on February 26, 2023. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $98.18 | Direct | 0 |
Reported balance
After 2026-03-23 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-03-23 · Disposition to issuer · Disposed 12,875 · Balance 0 F4: At the Effective Time, each option to purchase shares of Common Stock granted under an Issuer stock plan and outstanding and unexercised as of immediately prior to the Effective Time was cancelled and, in the case of any such option the per-share exercise price of which was less than the Merger Consideration, converted into the right to receive a cash payment equal to the number of shares of Common Stock for which such option was exercisable multiplied by the excess of the Merger Consideration over the per-share exercise price of such option, less any applicable tax withholding F6: These options became exercisable on February 14, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: On March 23, 2026, pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of November 19, 2025, by and among Exact Sciences Corporation, a Delaware corporation (the "Issuer"), Abbott Laboratories, an Illinois corporation ("Parent"), and Badger Merger Sub I, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a direct, wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), on the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), issued and outstanding immediately prior to the Effective Time, with certain exceptions, was converted into the right to receive $105.00 in cash, without interest (the "Merger Consideration").
F2: At the Effective Time, each share of Common Stock subject to vesting, repurchase or other lapse restriction and that was granted under an Issuer stock plan and outstanding as of immediately prior to the Effective Time was deemed to be fully vested and cancelled and converted into the right to receive the Merger Consideration, less any applicable tax withholding.
F3: These options became exercisable on February 27, 2022.
F4: At the Effective Time, each option to purchase shares of Common Stock granted under an Issuer stock plan and outstanding and unexercised as of immediately prior to the Effective Time was cancelled and, in the case of any such option the per-share exercise price of which was less than the Merger Consideration, converted into the right to receive a cash payment equal to the number of shares of Common Stock for which such option was exercisable multiplied by the excess of the Merger Consideration over the per-share exercise price of such option, less any applicable tax withholding
F5: These options became exercisable on February 26, 2023.
F6: These options became exercisable on February 14, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2018 Filed Oct 2, 2018 16:28 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 4,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-053144 · doc4.xml · derivative · entry 4 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,687 Underlying: Common Stock · 4,688 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Represents a restricted stock unit award granted on January 1, 2015 that partially vested on September 30, 2018. The restricted stock units vest as follows: one-quarter on the first anniversary of the grant date and the balance in equal quarterly installments over the three year period beginning on the one-year anniversary of the grant date. F4 · derivative.expiration_date: Represents a restricted stock unit award granted on January 1, 2015 that partially vested on September 30, 2018. The restricted stock units vest as follows: one-quarter on the first anniversary of the grant date and the balance in equal quarterly installments over the three year period beginning on the one-year anniversary of the grant date. Read SEC document |
| September 30, 2018 Filed Oct 2, 2018 16:28 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 4,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-053144 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,047 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award on September 30, 2018. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 16:10 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 2,135 | $59.10 | $126,176.37 |
DisclosureSEC source: 0001209191-18-040959 · doc4.xml · nonDerivative · entry 3 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,359 F3 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on June 30, 2018. Read SEC document |
| June 30, 2018 Filed Jul 3, 2018 16:10 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 4,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-040959 · doc4.xml · derivative · entry 5 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,375 Underlying: Common Stock · 4,687 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Represents a restricted stock unit award granted on January 1, 2015 that partially vested on June 30, 2018. The restricted stock units vest as follows: one-quarter on the first anniversary of the grant date and the balance in equal quarterly installments over the three year period beginning on the one-year anniversary of the grant date. F5 · derivative.expiration_date: Represents a restricted stock unit award granted on January 1, 2015 that partially vested on June 30, 2018. The restricted stock units vest as follows: one-quarter on the first anniversary of the grant date and the balance in equal quarterly installments over the three year period beginning on the one-year anniversary of the grant date. Read SEC document |
| June 30, 2018 Filed Jul 3, 2018 16:10 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 4,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-040959 · doc4.xml · nonDerivative · entry 2 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,494 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award on June 30, 2018. Read SEC document |
| April 30, 2018 Filed Jul 3, 2018 16:10 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantCommon Stock | 3,806 | $5.95 | $22,645.70 |
DisclosureSEC source: 0001209191-18-040959 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,807 F1 · shares: Represents shares purchased through Employee Stock Purchase Plan. Read SEC document |
| April 02, 2018 Filed Apr 3, 2018 16:51 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 2,122 | $40.12 | $85,124.03 |
DisclosureSEC source: 0001209191-18-023080 · doc4.xml · nonDerivative · entry 2 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,001 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on March 31, 2018. Read SEC document |
| March 31, 2018 Filed Apr 3, 2018 16:51 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 4,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-023080 · doc4.xml · derivative · entry 4 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,062 Underlying: Common Stock · 4,688 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Represents a restricted stock unit award granted on January 1, 2015 that partially vested on March 31, 2018. The restricted stock units vest as follows: one-quarter on the first anniversary of the grant date and the balance in equal quarterly installments over the three-year period beginning on the one-year anniversary of the grant date. F4 · derivative.expiration_date: Represents a restricted stock unit award granted on January 1, 2015 that partially vested on March 31, 2018. The restricted stock units vest as follows: one-quarter on the first anniversary of the grant date and the balance in equal quarterly installments over the three-year period beginning on the one-year anniversary of the grant date. Read SEC document |
| March 31, 2018 Filed Apr 3, 2018 16:51 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 4,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-023080 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,123 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
| March 12, 2018 Filed Mar 13, 2018 16:48 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 2,708 | $52.19 | $141,341.35 |
DisclosureSEC source: 0001209191-18-019252 · doc4.xml · nonDerivative · entry 2 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,435 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on March 9, 2018. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 16:48 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 6,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019252 · doc4.xml · derivative · entry 4 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,025 Underlying: Common Stock · 6,025 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Represents a restricted stock unit award granted on March 9, 2015 that partially vested on March 9, 2018. The restricted stock units vest in four equal annual installments beginning on March 9, 2016. F4 · derivative.expiration_date: Represents a restricted stock unit award granted on March 9, 2015 that partially vested on March 9, 2018. The restricted stock units vest in four equal annual installments beginning on March 9, 2016. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 16:48 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 6,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-019252 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
| February 27, 2018 Filed Feb 28, 2018 16:53 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantRestricted Stock Units · Derivative | 20,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-014573 · doc4.xml · derivative · entry 6 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,100 Underlying: Common Stock · 20,100 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 27, 2018 Filed Feb 28, 2018 16:53 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantStock Option (right to buy) · Derivative | 16,700 | $0.00 Strike: $44.37 | $0.00 |
DisclosureSEC source: 0001209191-18-014573 · doc4.xml · derivative · entry 5 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,700 Underlying: Common Stock · 16,700 shares Expires 2028-02-27 F5 · derivative.exercise_date: These options vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 27, 2018 Filed Feb 28, 2018 16:53 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 9,292 | $44.10 | $409,758.62 |
DisclosureSEC source: 0001209191-18-014573 · doc4.xml · nonDerivative · entry 2 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,118 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 26, 2018. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 18:20 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 4,420 | $42.34 | $187,133.96 |
DisclosureSEC source: 0001209191-18-014134 · doc4.xml · nonDerivative · entry 2 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,010 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 23, 2018. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 16:53 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 21,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-014573 · doc4.xml · derivative · entry 4 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,800 Underlying: Common Stock · 21,400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Represents a restricted stock unit award granted on February 26, 2016 that partially vested on February 26, 2018. The restricted stock units vest in four equal annual installments beginning on February 26, 2017. F4 · derivative.expiration_date: Represents a restricted stock unit award granted on February 26, 2016 that partially vested on February 26, 2018. The restricted stock units vest in four equal annual installments beginning on February 26, 2017. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 16:53 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 21,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-014573 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,410 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 18:20 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 12,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-014134 · doc4.xml · derivative · entry 4 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,550 Underlying: Common Stock · 12,850 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Represents a restricted stock unit award granted on February 23, 2017 that partially vested on February 23, 2018. The restricted stock units vest in four equal annual installments beginning on February 23, 2018. F4 · derivative.expiration_date: Represents a restricted stock unit award granted on February 23, 2017 that partially vested on February 23, 2018. The restricted stock units vest in four equal annual installments beginning on February 23, 2018. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 18:20 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 12,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-014134 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
| January 03, 2018 Filed Jan 4, 2018 17:32 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 1,665 | $52.54 | $87,474.11 |
DisclosureSEC source: 0001209191-18-002086 · doc4.xml · nonDerivative · entry 3 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,580 F3 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on December 31, 2017. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 17:32 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 4,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-002086 · doc4.xml · derivative · entry 5 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Underlying: Common Stock · 4,687 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Represents a restricted stock unit award granted on January 1, 2015 that partially vested on December 31, 2017 and which shares were delivered on January 2, 2018. The restricted stock units vest as follows: one-quarter on the first anniversary of the grant date and the balance in equal quarterly installments over the three year period beginning on the one-year anniversary of the grant date. F5 · derivative.expiration_date: Represents a restricted stock unit award granted on January 1, 2015 that partially vested on December 31, 2017 and which shares were delivered on January 2, 2018. The restricted stock units vest as follows: one-quarter on the first anniversary of the grant date and the balance in equal quarterly installments over the three year period beginning on the one-year anniversary of the grant date. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 17:32 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 4,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-002086 · doc4.xml · nonDerivative · entry 2 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,245 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award on December 31, 2017 and delivered on January 2, 2018. Read SEC document |
| October 31, 2017 Filed Jan 4, 2018 17:32 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantCommon Stock | 1,682 | $5.95 | $10,007.90 |
DisclosureSEC source: 0001209191-18-002086 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,558 F1 · shares: Represents shares purchased through Employee Stock Purchase Plan. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 17:14 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 26,884 | $47.16 | $1,267,930.09 |
DisclosureSEC source: 0001209191-17-055247 · doc4.xml · nonDerivative · entry 3 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,876 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2017. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.641 to $47.530, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 17:14 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 2,231 | $47.15 | $105,184.96 |
DisclosureSEC source: 0001209191-17-055247 · doc4.xml · nonDerivative · entry 2 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,760 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on September 30, 2017. Read SEC document |
| September 29, 2017 Filed Oct 3, 2017 17:14 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 4,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-055247 · doc4.xml · derivative · entry 5 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,437 Underlying: Common Stock · 4,688 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Represents a restricted stock unit award granted on January 1, 2015 that partially vested on September 30, 2017. The restricted stock units vest as follows: one-quarter on the first anniversary of the grant date and the balance in equal quarterly installments over the three year period beginning on the one-year anniversary of the grant date. F6 · derivative.expiration_date: Represents a restricted stock unit award granted on January 1, 2015 that partially vested on September 30, 2017. The restricted stock units vest as follows: one-quarter on the first anniversary of the grant date and the balance in equal quarterly installments over the three year period beginning on the one-year anniversary of the grant date. Read SEC document |
| September 29, 2017 Filed Oct 3, 2017 17:14 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 4,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-055247 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
| July 27, 2017 Filed Jul 28, 2017 16:16 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantRestricted Stock Units · Derivative | 51,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-046569 · doc4.xml · derivative · entry 4 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,400 Underlying: Common Stock · 51,400 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · date: This restricted stock unit award was granted by the Compensation Committee of the Company's Board of Directors on February 23, 2017, contingent upon stockholder approval of the Plan Amendment. The Company's stockholders approved the Plan Amendment at the Company's 2017 Annual Meeting of Stockholders on July 27, 2017. F5 · derivative.exercise_date: These restricted stock units vest in four equal annual installments beginning on February 23, 2018. F5 · derivative.expiration_date: These restricted stock units vest in four equal annual installments beginning on February 23, 2018. Read SEC document |
| July 27, 2017 Filed Jul 28, 2017 16:16 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $21.68 | $0.00 |
DisclosureSEC source: 0001209191-17-046569 · doc4.xml · derivative · entry 3 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2027-02-23 F1 · date: This option award was granted by the Compensation Committee of the Board of Directors of Exact Sciences Corporation (the "Company") on February 23, 2017, contingent upon stockholder approval of Amendment No. 1 to the Company's 2010 Omnibus Long-Term Incentive Plan (As Amended and Restated Effective April 28, 2015) (the "Plan Amendment"). The Company's stockholders approved the Plan Amendment at the Company's 2017 Annual Meeting of Stockholders on July 27, 2017. F2 · derivative.exercise_date: These options vest and become exercisable in four equal annual installments beginning on February 23, 2018. Read SEC document |
| July 03, 2017 Filed Jul 5, 2017 16:18 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 1,987 | $35.21 | $69,962.27 |
DisclosureSEC source: 0001209191-17-043306 · doc4.xml · nonDerivative · entry 3 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,303 F3 · shares: Represents shares of common stock sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on June 30, 2017. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 16:18 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 4,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-043306 · doc4.xml · derivative · entry 5 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,125 Underlying: Common Stock · 4,687 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Represents a restricted stock unit award granted on January 1, 2015 that partially vested on June 30, 2017. The restricted stock units vest as follows: one-quarter on the first anniversary of the grant date and the balance in equal quarterly installments over the three year period beginning on the one-year anniversary of the grant date. F5 · derivative.expiration_date: Represents a restricted stock unit award granted on January 1, 2015 that partially vested on June 30, 2017. The restricted stock units vest as follows: one-quarter on the first anniversary of the grant date and the balance in equal quarterly installments over the three year period beginning on the one-year anniversary of the grant date. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 16:18 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 4,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-043306 · doc4.xml · nonDerivative · entry 2 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
| May 01, 2017 Filed Jul 5, 2017 16:18 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantCommon Stock | 3,668 | $5.95 | $21,824.60 |
DisclosureSEC source: 0001209191-17-043306 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,603 F1 · shares: Represents shares of common stock purchased through Employee Stock Purchase Plan. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 16:43 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 1,543 | $23.74 | $36,630.82 |
DisclosureSEC source: 0001209191-17-024888 · doc4.xml · nonDerivative · entry 2 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,935 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on March 31, 2017. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 16:43 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 4,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-024888 · doc4.xml · derivative · entry 4 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,812 Underlying: Common Stock · 4,688 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Represents a restricted stock unit award granted on January 1, 2015 that partially vested on March 31, 2017. The restricted stock units vest as follows: one-quarter on the first anniversary of the grant date and the balance in equal quarterly installments over the three year period beginning on the one-year anniversary of the grant date. F4 · derivative.expiration_date: Represents a restricted stock unit award granted on January 1, 2015 that partially vested on March 31, 2017. The restricted stock units vest as follows: one-quarter on the first anniversary of the grant date and the balance in equal quarterly installments over the three year period beginning on the one-year anniversary of the grant date. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 16:43 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 4,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-024888 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,478 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 16:27 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 1,983 | $21.16 | $41,960.28 |
DisclosureSEC source: 0001209191-17-020517 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,790 F1 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on March 9, 2017. Read SEC document |
| March 09, 2017 Filed Mar 13, 2017 19:35 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 6,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-020339 · doc4.xml · derivative · entry 3 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,050 Underlying: Common Stock · 6,025 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Represents a restricted stock unit award granted on March 9, 2015 that partially vested on March 9, 2017. The restricted stock units vest in four equal annual installments beginning on March 9, 2016. F3 · derivative.expiration_date: Represents a restricted stock unit award granted on March 9, 2015 that partially vested on March 9, 2017. The restricted stock units vest in four equal annual installments beginning on March 9, 2016. Read SEC document |
| March 09, 2017 Filed Mar 13, 2017 19:35 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 6,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-020339 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,773 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
| February 27, 2017 Filed Feb 28, 2017 20:57 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 7,046 | $21.48 | $151,348.08 |
DisclosureSEC source: 0001209191-17-015566 · doc4.xml · nonDerivative · entry 2 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,748 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 26, 2017. Read SEC document |
| February 26, 2017 Filed Feb 28, 2017 20:57 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 21,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015566 · doc4.xml · derivative · entry 4 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,200 Underlying: Common Stock · 21,400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Represents a restricted stock unit award granted on February 26, 2016 that partially vested on February 26, 2017. The restricted stock units vest in four equal annual installments beginning on February 26, 2017. F4 · derivative.expiration_date: Represents a restricted stock unit award granted on February 26, 2016 that partially vested on February 26, 2017. The restricted stock units vest in four equal annual installments beginning on February 26, 2017. Read SEC document |
| February 26, 2017 Filed Feb 28, 2017 20:57 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 21,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015566 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,794 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 06:32 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 1,535 | $13.61 | $20,891.35 |
DisclosureSEC source: 0001209191-17-001648 · doc4.xml · nonDerivative · entry 3 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,394 F3 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on December 31, 2016. Read SEC document |
| December 31, 2016 Filed Jan 5, 2017 06:32 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 4,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-001648 · doc4.xml · derivative · entry 5 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 4,687 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Represents a restricted stock unit award granted on January 1, 2015 that partially vested on December 31, 2016. The restricted stock units vest as follows: one-quarter on the first anniversary of the grant date and the balance in equal quarterly installments over the three year period beginning on the one-year anniversary of the grant date. F5 · derivative.expiration_date: Represents a restricted stock unit award granted on January 1, 2015 that partially vested on December 31, 2016. The restricted stock units vest as follows: one-quarter on the first anniversary of the grant date and the balance in equal quarterly installments over the three year period beginning on the one-year anniversary of the grant date. Read SEC document |
| December 31, 2016 Filed Jan 5, 2017 06:32 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 4,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-001648 · doc4.xml · nonDerivative · entry 2 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,929 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
| October 31, 2016 Filed Jan 5, 2017 06:32 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantCommon Stock | 1,558 | $5.95 | $9,270.10 |
DisclosureSEC source: 0001209191-17-001648 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,242 F1 · shares: Represents shares purchased through Employee Stock Purchase Plan. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 16:11 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 1,701 | $17.98 | $30,583.98 |
DisclosureSEC source: 0001209191-16-144152 · doc4.xml · nonDerivative · entry 2 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,684 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on September 30, 2016. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 16:11 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 4,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-144152 · doc4.xml · derivative · entry 4 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,187 Underlying: Common Stock · 4,688 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Represents a restricted stock unit award granted on January 1, 2015 that partially vested on September 30, 2016. The restricted stock units vest as follows: one-quarter on the first anniversary of the grant date and the balance in equal quarterly installments over the three year period beginning on the one-year anniversary of the grant date. F4 · derivative.expiration_date: Represents a restricted stock unit award granted on January 1, 2015 that partially vested on September 30, 2016. The restricted stock units vest as follows: one-quarter on the first anniversary of the grant date and the balance in equal quarterly installments over the three year period beginning on the one-year anniversary of the grant date. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 16:11 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 4,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-144152 · doc4.xml · nonDerivative · entry 1 COWARD D SCOTT · CIK 0001247296 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,385 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.